Nomogram prediction for overall survival of patients diagnosed with cervical cancer

British Journal of Cancer

Volumn 107, Issue 6, 2012, Pages 918-924

  Polterauer, S ^a   Grimm, C ^a   Hofstetter, G ^b   Concin, N ^b   Natter, C ^a   Sturdza, A ^a   Potter R ^a   Marth, C ^b   Reinthaller, A ^a,c   Heinze, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Karl Landsteiner Institute for General Gynecology and Experimental Gynecologic Oncology   (Austria)

Author keywords

cervical cancer; nomogram; prediction model; prognosis; surgery; survival

Indexed keywords

ACCURACY; ADULT; ARTICLE; CALCULATION; CANCER MORTALITY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NOMOGRAM; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL MODEL; UTERINE CERVIX CANCER; VALIDATION PROCESS;

ADENOCARCINOMA; ADULT; AGED; AREA UNDER CURVE; AUSTRIA; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE; UTERINE CERVICAL NEOPLASMS;

EID: 84865860458     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.340     Document Type: Article

References (29)

1. Abu-Rustum NR, Zhou Q, Gomez JD, Alektiar KM, Hensley ML, Soslow RA, Levine DA, Chi DS, Barakat RR, Iasonos A (2010) A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. Gynecol Oncol 116: 399-403
2. Ambler G, Seaman S, Omar R (2012) An evaluation of penalised survival methods for developing prognostic models with rare events. Stat Med 31: 1150-1161
3. Benedet JL, Bender H, Jones 3rd H, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70: 209
4. Brockbank E, Kokka F, Bryant A, Pomel C, Reynolds K (2011) Pretreatment surgical para-aortic lymph node assessment in locally advanced cervical cancer. Cochrane Database Syst Rev 4: CD008217
5. Chen RJ, Lin YH, Chen CA, Huang SC, Chow SN, Hsieh CY (1999) Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol 73: 184-190
6. Chi DS, Palayekar MJ, Sonoda Y, Abu-Rustum NR, Awtrey CS, Huh J, Eisenhauer EL, Barakat RR, Kattan MW (2008) Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma. Gynecol Oncol 108: 191-194
7. Committee on Practice Bulletins-Gynecology. ACOG practice bulletin(2002) Diagnosis and treatment of cervical carcinomas, number 35, May 2002. Obstet Gynecol,99, 855
8. Creasman WT, Kohler MF (2004) Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol 92: 525
9. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F (1990) Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38: 352
10. Galic V, Herzog TJ, Lewin SN, Neugut AI, Burke WM, Lu YS, Hershman DL, Wright JD (2012) Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol 125(2): 287-291
11. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Huh WK, Jaggernauth W, Kapp DS, Kavanagh J, Lipscomb GH, Lurain 3rd JR, Morgan M, Morgan Jr RJ, Powell CB, Remmenga SW, Reynolds RK, Secord AA, Small Jr W, Teng N, National Comprehensive Cancer Network. Cervical cancer (2008) J Natl Compr Canc Netw 6: 14-36
12. Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56: 337-344
13. Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH, Koelliker S, Siegelman ES, Brown JJ, McGhee Jr RB, Iyer R, Vitellas KM, Snyder B, Long 3rd HJ, Fiorica JV, Mitchell DG, American College of Radiology Imaging Network 6651; Gynecologic Oncology Group 183 (2005) Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 23: 9329-9337
14. Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26: 1364-1370
15. Inoue T, Morita K (1990) The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 65: 1923
16. Kastritis E, Bamias A, Bozas G, Koutsoukou V, Voulgaris Z, Vlahos G, Rodolakis A, Gika D, Papadimitriou C, Dimopoulos MA (2007) The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy. Gynecol Oncol 104: 372-376
17. Kim MK, Jo H, Kong HJ, Kim HC, Kim JW, Kim YM, Song YS, Kang SB, Mok JE, Lee HP (2010) Postoperative nomogram predicting risk of recurrence after radical hysterectomy for early-stage cervical cancer. Int J Gynecol Cancer 20: 1581-1586
18. Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA (1980) Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol 9: 90
19. Pecorelli S, Zigliani L, Odicino F (2009) Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 105: 107-108
20. Pötter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, Georg D, Schmid MP, Reinthaller A, Sturdza A, Kirisits C (2011) Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 100: 116-123
21. Polterauer S, Hefler L, Seebacher V, Rahhal J, Tempfer C, Horvat R, Reinthaller A, Grimm C (2010) The impact of lymph node density on survival of cervical cancer patients. Br J Cancer 103: 613-626
22. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY, Pecorelli S (2006) Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95: 103
23. Royston P, Altman DG (1994) Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. Applied Statistics 43: 429-467
24. Simon N, Friedman J, Hastie T, Tibshirani R (2011) Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent. J Stat Software 39: 1-13
25. Statistik Austria (2011) Krebsinzidenz und Krebsmortalität in Ö sterreich 2010. (ISBN 978-3-902703-42-2)
26. Steyerberg EW (2009) Clinical Prediction Models. A Practical Approach to Development, Validation, and Updating. Series title: Statistics for Biology and Health, p.95f. Springer: New York, ISBN: 978-0-387-77243-1 doi:10.1007/978-0- 387-77244-8
27. Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, Oikawa M, Yamamoto R, Yamada H, Fujimoto S (2002) Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 81: 1144-1151
28. Tseng JY, Yen MS, Twu NF, Lai CR, Horng HC, Tseng CC, Chao KC, Juang CM (2010) Prognostic nomogram for overall survival in stage IIB-IVA cervical cancer patients treated with concurrent chemoradiotherapy. Am J Obstet Gynecol 202(2): 174.e1-e7
29. Uno H, Cai T, Pencina MJ, D'Agostino RB, Wei LJ (2011) On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med 30: 1105-1117